Keywords
Pregnancy Complications
CD4 Lymphocyte Count
Viral Loud
Human Immunodeficiency Virus
How to Cite
Abstract
Introduction: HIV-positive pregnant women could present different pregnancy complications related to both their immunological status and retroviral therapy. Objective: to relate the immunological parameters with the obstetric complications presented by pregnant women seropositive to the Human Immunodeficiency Virus (HIV) attended in a Venezuelan maternity hospital. Method: a retrospective correlational study, where a sample of 161 HIV-positive pregnant women was studied; analyzing obstetric complications, CD4+ count and viral load. Results: the most common maternal pathologies were: anemia (57.76%); while fetal and ovular complications prevailed low birth weight (13.04%) and premature rupture of membranes (13.04%), respectively. A higher and significant frequency of morbidities was evidenced in women with CD4+= 200-499 cells/ml and viral load >1,000 copies/ml for most pathologies; a lower CD4+ count was associated with a highly significant risk of presenting pathologies such as anemia (OR= 14.44; 95%CI 05.94-35.08), low birth weight (OR= 5.94; 95%CI 02 0.05-17.20) and urinary tract infection (OR= 3.38; 95% CI 1.74-6.55). Viral load was not associated with increased risk of obstetric complications. Conclusions: HIV infection is associated with a higher risk of obstetric complications in relation to immunological status.References
Mejía JV, Bastos TR, Freire D, da Costa AM, Marques S, Abrão FM. Representaciones sociales del VIH construidas por jóvenes embarazadas atendidas en un hospital universitario de Recife-Brasil. Index Enferm. 2021; 30 (3): 209-213, 2021.
Gámez A, López MA. Resultados del embarazo en mujeres con infección por virus de la inmunodeficiencia humana. Actual Med. 2020; 105: (810): 96-102 http://dx.doi.org/10.15568/am.2020.810.or03
Carvajal AC, Rísquez A, Oletta JF, Godoy O. Epidemiología del VIH en Venezuela desde 1983 a 2016. Med Interna. 2019; 35 (2): 79 – 93
Carvajal A, Castrillo M, Miguel M, Francia M, Castrillo S, Morillo M, et al. Características epidemiológicas y otros indicadores en mujeres infectadas con el Virus de Inmunodeficiencia Humana (VIH) en Venezuela. Trabajo colaborativo. Gac Méd Caracas. 2016; 124 (2): 138-148.
Programa Conjunto de las Naciones Unidas sobre el VIH/SIDA/Organización Panamericana de la Salud – Organización Mundial de la Salud Venezuela: Plan Maestro para el fortalecimiento de la respuesta al VIH, la tuberculosis y la malaria en la República Bolivariana de Venezuela desde una perspectiva de salud pública; 2018.
Rincón S, Uriel M, Rodríguez LM, Romero Infante XC. Preventive measures to avoid vertical transmission in untreated pregnant women with HIV/AIDS. BMJ Case Rep. 2020 Mar 25;13 (3): e233426. http://dx.doi.org/10.1136/bcr-2019-233426
Bailey H, Zash R, Rasi V, Thorne C. HIV treatment in pregnancy. Lancet HIV. 2018; 5 (8): e457– e467. http://dx.doi.org/10.1016/S2352-3018(18)30059-6
Valdés E, Sepúlveda A, Candia P, Sepúlveda C, Lattes K. VIH/SIDA: Comportamiento epidemiológico de la transmisión vertical en el contexto general de la infección en Chile. Rev Chil Obstet Ginecol. 2011; 76 (1): 52 – 57. http://dx.doi.org/10.4067/S0717-75262011000100011
Gómez AC, Carrillo ME, Rodríguez JA. Morbimortalidad materno-perinatal en pacientes con infección por VIH, Hospital Simón Bolívar, 2003-2011, Bogotá (Colombia). Rev Colomb Obstet Ginecol. 2014; 65 (4): 308 – 316. http://dx.doi.org/10.18597/rcog.34
Ministerio del Poder Popular para la Salud. Guía de Tratamiento Antirretroviral de las personas que viven con el VIH/Sida en Venezuela. Programa Nacional de SIDA/ITS del Ministerio del Poder Popular para la Salud (2014-2016). 5ta. Ed. Caracas, Venezuela: Ministerio del Poder Popular para la Salud; 2014.
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antirretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. October 14, 2011; 1-167
Ikpim EM, Edet UA, Bassey AU, Asuquo OA, Inyang EE. HIV infection in pregnancy: maternal and perinatal outcomes in a tertiary care hospital in Calabar, Nigeria. Trop Doct. 2016; 46 (2): 78-86. http://dx.doi.org/10.1177/0049475515605003
Odhiambo C, Zeh C, Angira F, Opollo V, Akinyi B, Masaba R, et al. Anaemia in HIV-infected pregnant women receiving triple antiretroviral combination therapy for prevention of mother-to-child transmission: a secondary analysis of the Kisumu breastfeeding study (KiBS). Trop Med Int Health. 2016; 21 (3): 373-384. http://dx.doi.org/10.1111/tmi.12662
Finkelstein JL, Herman HS, Plenty A, Mehta S, Natureeba P, Clark TD, et al. Anemia and Micronutrient Status during Pregnancy, and Their Associations with Obstetric and Infant Outcomes among HIV-Infected Ugandan Women Receiving Antiretroviral Therapy. Curr Dev Nutr. 2020; 4 (5): nzaa075. http://dx.doi.org/10.1093/cdn/nzaa075
Tanton C, Weiss HA, Le Goff J. Correlates of HIV-1 genital shedding in Tanzanian women. PLoS ONE. 2011 Mar; 6 (3): e17480. http://dx.doi.org/10.1371/journal.pone.0017480
Ray A, Ray S, George AT, Swaminathan N. Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection. Cochrane Database of Syst Rev. 2011; 8: CD008739. http://dx.doi.org/10.1002/14651858.CD008739.pub2
Lamont RF, Sobel JD, Akins RA, Hassan SS, Chaiworapongsa T, Kusanovic JP, et al. The vaginal microbiome: New information about genital tract flora using molecular based techniques. BJOG. 2011; 118 (5): 533–549. http://dx.doi.org/10.1111/j.1471-0528.2010.02840.x
Vallone C, Rigon G, Lucantoni V, Putignani L, Signore F. Pregnancy in HIV-Positive Patients: Effects on Vaginal Flora. Infect Dis Obstet Gynecol. 2012; 2012: 287849 http://dx.doi.org/10.1155/2012/287849
Foessleitner P, Petricevic L, Boerger I, Steiner I, Kiss H, Rieger A, et al. HIV infection as a risk factor for vaginal dysbiosis, bacterial vaginosis, and candidosis in pregnancy: A matched case-control study. Birth. 2021; 48 (1): 139-146. http://dx.doi.org/10.1111/birt.12526
Arab K, Czuzoj-Shulman N, Spence A, Abenhaim HA. Obstetrical Outcomes of Patients with HIV in Pregnancy, a Population Based Cohort, Arch Gynecol Obstet. 2017; 295 (3): 599-606. http://dx.doi.org/10.1007/s00404-016-4271-y
Reitter A, Stücker AU, Linde R, Königs C, Knecht G, Herrmann E, et al. Pregnancy complications in HIV-positive women: 11-year data from the Frankfurt HIV Cohort. HIV Med. 2014; 15 (9): 525–536. http://dx.doi.org/10.1111/hiv.12142
Akadri AA, Odelola OI. Determinants of Asymptomatic Bacteriuria in HIV-positive and Negative Pregnant Women in Sagamu, South-West Nigeria. West Afr J Med. 2020; 37 (1): 1-6.
Soriano A, Noguera A, López M, Soler P, Mur A, Méndez M, et al. El embarazo como una oportunidad de diagnóstico del virus de la inmunodeficiencia humana en mujeres inmigrantes en Catalunya. Enferm Infecc Microbiol Clin. 2018; 36 (1): 9–15. http://dx.doi.org/10.1016/j.eimc.2016.07.011
Wang A, Wang X, Dou L, Wang F, Wang Q, Qiao Y, et al. Incidence of and related risk factors on preterm delivery among HIV-infected pregnant women in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2015; 36 (4): 349-353.
Ehsanipoor RM, Major CA. Herpes Simplex and HIV Infections and Preterm PROM. Clin Obstet Gynecol. 2011; 54 (2): 330–360. http://dx.doi.org/10.1097/GRF.0b013e318217d7a6
Calvo M, de la Calle M, Montes ML, Escosa L, Elorza MD, González J, et al. Complicaciones obstétricas relacionadas con la terapia antirretroviral en gestantes infectadas por el VIH. Clín Inv Ginecol Obstet. 2022; 49: 100713. http://dx.doi.org/10.1016/j.gine.2021.100713
Xiao PL, Zhou YB, Chen Y, Yang MX, Song XX, Shi Y, et al. Association between maternal HIV infection and low birth weight and prematurity: a meta-analysis of cohort studies. BMC Pregnancy Childbirth. 2015; 15: 246. http://dx.doi.org/10.1186/s12884-015-0684-z
Mirpuri J, Jain L. Issues of prematurity and HIV infection. Clin Perinatol. 2010; 37(4): 887-905. http://dx.doi.org/10.1016/j.clp.2010.08.012
Burnett E, Loucks TL, Lindsay M. Perinatal outcomes in HIV positive pregnant women with concomitant sexually transmitted infections. Infect Dis Obstet Gynecol. 2015: 508482. http://dx.doi.org/10.1155/2015/508482
Obimbo MM, Zhou Y, McMaster MT, Cohen CR, Qureshi Z, Ong'ech J, et al. Placental Structure in Preterm Birth Among HIV-Positive Versus HIV-Negative Women in Kenya. J Acquir Immune Defic Syndr. 2019; 80(1): 94-102. http://dx.doi.org/10.1097/QAI.0000000000001871
European Collaborative Study, Boer K, England K, Godfried MH, Thorne C. Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: Changing practices in Western Europe. HIV medicine. 2010; 11(6): 368-378. http://dx.doi.org/10.1111/j.1468-1293.2009.00800.x
Yudin MH, Caprara D, MacGillivray SJ, Urquia M, Shah RR. A ten-year review of antenatal complications and pregnancy outcomes among HIV-positive pregnant Women. J Obstet Gynaecol Can. 2016; 38 (1): 35 - 40. http://dx.doi.org/10.1016/j.jogc.2015.10.013
Soepnel LM, Norris SA, Schrier VJ, Browne JL, Rijken MJ, Gray G, et al. The association between HIV, antiretroviral therapy, and gestational diabetes mellitus. Aids. 2017; 31: 113–125. http://dx.doi.org/10.1097/QAD.0000000000001277
Browne JL, Schrier VJ, Grobbee DE, Peters SA, Klipstein K. HIV, Antiretroviral Therapy, and Hypertensive Disorders in Pregnancy: A Systematic Review and Meta-analysis. J Acquir Immune Defic Syndr. 2015; 70(1): 91-98. http://dx.doi.org/10.1097/QAI.0000000000000686
Phoswa WN. The Role of HIV Infection in the Pathophysiology of Gestational Diabetes Mellitus and Hypertensive Disorders of Pregnancy. Front Cardiovasc Med. 2021; 8: 613930. http://dx.doi.org/10.3389/fcvm.2021.613930
Organización Panamericana de la Salud. Nuevas generaciones sin la infección por el VIH, la sífilis, la hepatitis B y la enfermedad de Chagas en las Américas 2018. Whashignton, D.C.; 2019
Phoswa WN, Eche S, Khaliq OP. The Association of Tuberculosis Mono-infection and Tuberculosis-Human Immunodeficiency Virus (TB-HIV) Co-infection in the Pathogenesis of Hypertensive Disorders of Pregnancy. Curr Hypertens Rep. 2020; 22 (12): 104. http://dx.doi.org/10.1007/s11906-020-01114-5
Juganariu G, Teodor A, Petrovici C, Cristina N, Miftode E. Characteristics of hepatitis B virus coinfection among hiv-infected pregnant women. Rev Med Chir Soc Med Nat Iasi. 2015; 119 (4): 1010 - 1017.
Kim HY, Kasonde P, Mwiya M. Pregnancy loss and role of infant HIV status on perinatal mortality among HIV-infected women. BMC Pediatr. 2012; 12: 138. http://dx.doi.org/10.1186/1471-2431-12-138
Moodley Y, Tomita A, de Oliveira T, Tanser F. HIV viral load and pregnancy loss: results from a population-based cohort study in rural KwaZulu-Natal, South Africa. Aids. 2021; 35 (5): 829-833. http://dx.doi.org/10.1097/QAD.0000000000002799
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright (c) 2023 Universidad del Magdalena